Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT06692140

Comparison of an Ultra-low Strut Thickness Everolimus-eluting Biodegradable Polymer Stent Versus Durable Polymer Everolimus-eluting Stents in Patients Treated with Percutaneous Coronary Intervention

Led by Odense University Hospital · Updated on 2024-12-09

3150

Participants Needed

3

Research Sites

397 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The objective of this randomized study is to compare the safety and efficacy of the ultra-low strut thickness everolimus-eluting biodegradable polymer Evermine50 stent to the everolimus-eluting family stents (durable polymer everolimus-eluting Xience or Promus stents) in a population-based setting with coronary artery stenosis treated with percutaneous coronary intervention

CONDITIONS

Official Title

Comparison of an Ultra-low Strut Thickness Everolimus-eluting Biodegradable Polymer Stent Versus Durable Polymer Everolimus-eluting Stents in Patients Treated with Percutaneous Coronary Intervention

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients aged 18 years or older eligible for treatment with one or more drug-eluting coronary stents
Not Eligible

You will not qualify if you...

  • Age under 18 years
  • Unable to consent to study participation (e.g., intubated patients)
  • Unstable condition or cardiogenic shock preventing understanding of study information and purpose
  • Do not speak Danish
  • Already included in the SORT OUT XII study
  • Life expectancy less than 1 year
  • Allergic to study-related treatment

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 3 locations

1

Aalborg University Hospital

Aalborg, Denmark, 9000

Actively Recruiting

2

Aarhus University Hospital

Aarhus, Denmark, 8200

Actively Recruiting

3

Odense University Hospital

Odense, Denmark, 5000

Actively Recruiting

Loading map...

Research Team

L

Lisette O Jensen, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here